2003, Doctors, FDA Approval and Licensing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

Doctors

FDA Approval

Licensing

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

FDA Law Blog: Biosimilars

FEBRUARY 11, 2024

Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. Rescheduling would eliminate a tax burden on cannabis companies, allowing licensed companies to expand investments into state programs and focus on public health in collaboration with law enforcement efforts.

Regulations

Regulations Production FDA Approval Marketing

NPP, DCC, And FDA-Regulated Medical Products

Drug & Device Law

MAY 26, 2023

A hundred years later, we detailed three rounds of litigation over Massachusetts’ serial efforts to ban, or at least substantially limit, the use of FDA-approved pain medications. 644 (2003), but not to Pike. Other state laws affecting FDA-approved drugs are more likely to have the required protectionist bent.

Regulations

Regulations Production FDA FDA Approval

Drug Discovery Digest

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

NPP, DCC, And FDA-Regulated Medical Products

Stay Connected